Skip to main content

Lizzul Paul F.'s Form 4 filing

Anaptysbio, Inc (ANAB) · filed Jan 8, 2026

Accession no.
0001711462-26-000004
Filed
Jan 8, 2026
Trade date
Jan 6-7, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market sales total $100.8K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Lizzul Paul F.CIK 0001711462Officer (Chief Medical Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 6, 2026Common StockMOption exerciseAcquired+6,145–F1–39,448Direct
Jan 7, 2026Common StockSSaleDisposed−2,235$45.11−$100,820.8537,213Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 6, 2026Common StockMOption exerciseDisposed−6,145$0.00$06,145Direct
Jan 6, 2026Common StockAGrant or awardAcquired+21,400$0.00$021,400Direct
Jan 6, 2026Common StockAGrant or awardAcquired+29,000$0.00$029,000Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)